In late September and early October 2026, Travere Therapeutics reported new FILSPARI® (sparsentan) data across IgA ...

(Nasdaq: TVTX) today announced that on October 10, 2026, the Compensation Committee of its Board of Directors granted ...

The package includes 36,000 options at a $52.02 exercise price per share and 142,580 restricted stock units, vesting over ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

So the stock is attached to a real, maturing franchise. The question is what the mRNA platform is worth, and the honest ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie and Alkermes . AbbVie (ABBV) In a report released yesterday, Vamil Divan fr ...

Pharmaceutical & Biotech Stock Introductory Series, Part 2, Episode 1 / 12 Episodes Total]IntroductionLigand Pharmaceuticals ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Guggenheimanalyst Vamil Divan maintains $Travere Therapeutic(TVTX.US)$ with a buy rating, and maintains the target price at ...

Quince Therapeutics, Inc. announced that Effective as of October 8, 2026, John Militello, CPA, was appointed as Chief Financial Officer of the Company. John Militello, CPA, age 53, has served as Head ...

Join Us at the Blue Hope Bash to Support the Fight Against Colorectal Cancer / Blue Hope Bash Committee, cancer, colorectal ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...